Follow
Martin Stangel
Martin Stangel
Professor für Klinische Neuroimmunologie und Neurochemie, Medizinische Hochschule Hannover
Verified email at mh-hannover.de
Title
Cited by
Cited by
Year
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9242018
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients
S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ...
Journal of neuroinflammation 9, 1-17, 2012
8062012
Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis
JF Collawn, M Stangel, LA Kuhn, V Esekogwu, S Jing, IS Trowbridge, ...
Cell 63 (5), 1061-1072, 1990
6721990
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …
JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...
The Lancet Neurology 16 (12), 976-986, 2017
5682017
Glial response during cuprizone-induced de-and remyelination in the CNS: lessons learned
V Gudi, S Gingele, T Skripuletz, M Stangel
Frontiers in cellular neuroscience 8, 73, 2014
3932014
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination
T Skripuletz, D Hackstette, K Bauer, V Gudi, R Pul, E Voss, K Berger, ...
Brain 136 (1), 147-167, 2013
3812013
Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses
I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ...
Annals of neurology 79 (2), 206-216, 2016
3802016
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent
T Skripuletz, M Lindner, A Kotsiari, N Garde, J Fokuhl, F Linsmeier, ...
The American journal of pathology 172 (4), 1053-1061, 2008
3012008
Regional differences between grey and white matter in cuprizone induced demyelination
V Gudi, D Moharregh-Khiabani, T Skripuletz, PN Koutsoudaki, A Kotsiari, ...
Brain research 1283, 127-138, 2009
2642009
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ...
The Lancet Neurology 17 (1), 35-46, 2018
2572018
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
M Stangel, S Fredrikson, E Meinl, A Petzold, O Stüve, H Tumani
Nature Reviews Neurology 9 (5), 267-276, 2013
2492013
De-and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected
T Skripuletz, V Gudi, D Hackstette, M Stangel
Histology and histopathology, Vol. 26, nº12 (2011), 2011
2402011
Characterisation of microglia during de-and remyelination: can they create a repair promoting environment?
EV Voß, J Škuljec, V Gudi, T Skripuletz, R Pul, C Trebst, M Stangel
Neurobiology of disease 45 (1), 519-528, 2012
2122012
Towards the implementation of ‘no evidence of disease activity’in multiple sclerosis treatment: the multiple sclerosis decision model
M Stangel, IK Penner, BA Kallmann, C Lukas, BC Kieseier
Therapeutic advances in neurological disorders 8 (1), 3-13, 2015
1992015
Remyelinating strategies for the treatment of multiple sclerosis
M Stangel, HP Hartung
Progress in neurobiology 68 (5), 361-376, 2002
1932002
Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions
I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, K Hellwig, ...
Neurology: Neuroimmunology & Neuroinflammation 5 (6), e504, 2018
1902018
Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions
I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, K Hellwig, ...
Neurology: Neuroimmunology & Neuroinflammation 5 (6), e504, 2018
1902018
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination
M Lindner, S Heine, K Haastert, N Garde, J Fokuhl, F Linsmeier, C Grothe, ...
Neuropathology and applied neurobiology 34 (1), 105-114, 2008
1862008
Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica
C Trebst, P Raab, EV Voss, P Rommer, M Abu-Mugheisib, UK Zettl, ...
Nature Reviews Neurology 7 (12), 688-698, 2011
1842011
Fumaric acid and its esters: an emerging treatment for multiple sclerosis
D Moharregh-Khiabani, RA Linker, R Gold, M Stangel
Current neuropharmacology 7 (1), 60-64, 2009
1772009
The system can't perform the operation now. Try again later.
Articles 1–20